title: Conversion to tacrolimus immunosuppression in renal transplant recipients: 12-month follow-up.
authors.affiliation: Division of Organ Transplantation, Department of Surgery, Catholic University, Largo A. Gemelli 8, 00168 Rome, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Citterio
authors.forename: M C
authors.initials: MC
authors.lastname: Scatà
authors.forename: J
authors.initials: J
authors.lastname: Romagnoli
authors.forename: U
authors.initials: U
authors.lastname: Pozzetto
authors.forename: G
authors.initials: G
authors.lastname: Nanni
authors.forename: M
authors.initials: M
authors.lastname: Castagneto
mesh_terms: D000328:Adult; D003404:Creatinine / Q000097:blood*; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy / Q000473:pathology; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology* / Q000523:psychology; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D011788:Quality of Life; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine; D009173:Mycophenolic Acid; D016559:Tacrolimus